Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be Detrimental to the Interests of Hi-Tech Pharmacal

Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be
   Detrimental to the Interests of Hi-Tech Pharmacal Co., Inc. Shareholders

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New
York City, is investigating the Board of Directors of Hi-Tech Pharmacal Co.,
Inc.

PR Newswire

NEW YORK, Sept. 25, 2013

NEW YORK, Sept. 25, 2013 /PRNewswire/ -- Juan E. Monteverde, a partner at
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New
York City, is investigating the Board of Directors of Hi-Tech Pharmacal Co.,
Inc. ("Hi-Tech" or the "Company") (NasdaqGS: HITK) for potential breaches of
fiduciary duties in connection with their conduct related to the sale of the
Company to Akorn, Inc. (NasdaqGS: AKRX) in a deal valued at $640 million.
Under the terms of the proposed transaction, Hi-Tech's stockholders will
receive $43.50 in cash for each share of Hi-Tech common stock they own.
However, Hi-Tech has reached $44.30 in its 52-week high. On September 24,
2013, Hi-Tech filed a Preliminary Proxy Statement recommending that
shareholders approve the adoption of the Merger Agreement and approve the
transactions contemplated by the Merger Agreement.

(Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO)

Request more information now by clicking here: www.faruqilaw.com/HITK. There
is no cost or obligation to you.

The investigation focuses on whether Hi-Tech's Board of Directors breached
their fiduciary duties to the Company's stockholders by failing to conduct an
adequate and fair sales process prior to agreeing to this proposed
transaction, whether and by how much this proposed transaction undervalues the
Company to the detriment of Hi-Tech's shareholders.

Faruqi & Faruqi, LLP is a national law firm which represents investors and
individuals in class action litigation. The firm is focused on providing
exemplary legal services in complex litigation in the areas of securities,
shareholder, antitrust and consumer litigation, throughout all phases of
litigation. The firm has an experienced trial team which has achieved
significant victories on behalf of the firm's clients.

If you own common stock in Hi-Tech and wish to obtain additional information
and protect your investments free of charge, please visit us at
www.faruqilaw.com/HITK or contact Juan E. Monteverde, Esq. either via e-mail
at jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or (212)
983-9330.

Contact:

Faruqi & Faruqi, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Juan E. Monteverde, Esq.
jmonteverde@faruqilaw.com
Toll Free: (877) 247-4292
Phone:(212) 983-9330

Attorney Advertising. (C) 2013 Faruqi & Faruqi, LLP. The law firm responsible
for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior
results do not guarantee or predict a similar outcome with respect to any
future matter. We are happy to discuss your particular case.

SOURCE Faruqi & Faruqi, LLP

Website: www.faruqilaw.com
 
Press spacebar to pause and continue. Press esc to stop.